Expression of the P2X1 receptor remains in the type II spiral ganglion neurons in the mature rat cochlea.

Prakansha N Kumar, Srdjan M Vlajkovic, Peter R Thorne, Haruna Suzuki-Kerr

Abstract read

In one paragraph

Article in Purinergic signalling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Prakansha N KumarDepartment of Audiology, The University of Auckland, Auckland, New Zealand.

Srdjan M VlajkovicDepartment of Physiology, The University of Auckland, Faculty of Medical and Health Sciences, 85 Park Road, Grafton, Auckland, 1023, New Zealand.

Peter R ThorneDepartment of Audiology, The University of Auckland, Auckland, New Zealand.

Haruna Suzuki-KerrDepartment of Physiology, The University of Auckland, Faculty of Medical and Health Sciences, 85 Park Road, Grafton, Auckland, 1023, New Zealand. h.suzuki-kerr@auckland.ac.nz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our sense of hearing commences in the cochlea, the peripheral sensory organ for hearing. Spiral ganglion neurons (SGN) in the cochlea are primary auditory neurons responsible for auditory neurotransmission. There are two classes of SGNs: type I SGNs, which make up 90-95% of the SGN population, and type II SGNs, which make up the remainder. Previous studies have shown that SGNs express a combination of purinergic (P2X, P2Y and adenosine) receptors at the mRNA and protein levels. In this study, we have focused on the P2X1 receptor to characterise its expression pattern in the Wistar rat cochlea at postnatal day 8 and in adult (6-8-week-old) rats of both genders using immunohistochemistry. Our results show differential expression of P2X1 receptors in 9.4-14.2% of SGNs in the adult cochlea, and 14.2-23.3% in the cochlea of P8 pups. In most of these neurons, P2X1 receptors were co-expressed with peripherin-1, an established type II SGN marker. These results suggest a potential role for the P2X1 receptor as a modulator of auditory neurotransmission in type II spiral ganglion neurons.

Indexed as

CochleaNeuronsReceptors, Purinergic P2X1Spiral GanglionAnimalsFemaleImmunohistochemistryMaleRatsRats, WistarReceptors, Purinergic P2X1Adult ratAuditory neurotransmissionCochleaImmunohistochemistryP2X1 receptorSpiral ganglion neurons

Identifiers

PMID41579306

DOI10.1007/s11302-026-10129-7

PMCPMC12831720

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.